Загрузка...
Biomarker Use for Dementia with Lewy Body Diagnosis: Survey of U.S. Experts
BACKGROUND: Dementia with Lewy body (DLB) diagnostic criteria define “indicative” and “supportive” biomarkers, but clinical practice patterns are unknown. METHODS: An anonymous survey querying clinical use of diagnostic tests/biomarkers was sent to 38 center of excellence investigators. The survey i...
Сохранить в:
| Опубликовано в: : | Alzheimer Dis Assoc Disord |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904569/ https://ncbi.nlm.nih.gov/pubmed/33009039 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WAD.0000000000000414 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|